Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Pension: 2020-2022

  • Mereo BioPharma Group's Pension rose 17.18% to -$1.3 million in Q2 2022 from the same period last year, while for Jun 2022 it was -$1.3 million, marking a year-over-year increase of 17.18%. This contributed to the annual value of -$1.5 million for FY2021, which is 8.30% up from last year.
  • Mereo BioPharma Group's Pension amounted to -$1.3 million in Q2 2022, which was up 13.30% from -$1.5 million recorded in Q4 2021.
  • Mereo BioPharma Group's 5-year Pension high stood at -$1.3 million for Q2 2022, and its period low was -$1.7 million during Q4 2020.
  • For the 3-year period, Mereo BioPharma Group's Pension averaged around -$1.6 million, with its median value being -$1.6 million (2021).
  • Data for Mereo BioPharma Group's Pension shows a peak YoY climbed of 17.18% (in 2022) over the last 5 years.
  • Over the past 3 years, Mereo BioPharma Group's Pension (Quarterly) stood at -$1.7 million in 2020, then grew by 10.82% to -$1.5 million in 2021, then grew by 17.18% to -$1.3 million in 2022.
  • Its Pension was -$1.3 million in Q2 2022, compared to -$1.5 million in Q4 2021 and -$1.6 million in Q2 2021.